Ami Bavishi
Managing Director
Gilmartin Group LLC
Ami Bavishi, Managing Director, Gilmartin Group LLC
Ami is an experienced investor relations professional with over 15 years of experience in biotech investor relations, through both agency and corporate (in-house) roles. She is currently a Managing Director at Gilmartin Group LLC. Prior to joining Gilmartin, Ami was the Executive Director, Head of Investor Relations and Corporate Communications at Rallybio, where she was responsible for overseeing the Company’s investor relations (IR) and communications efforts, including shaping the IR and communications strategies. Prior to joining Rallybio, Ami was the Director of Investor Relations at Aerie Pharmaceuticals Inc., where she oversaw all IR activities. Ami spent the majority of her career in roles of increasing responsibility at Burns McClellan, a New York-based life science IR and public relations firm, where she developed and managed various public company IR programs for various biotechnology and specialty pharmaceutical clients, as well as oversaw several of the firm’s investor days. Outside of IR, Ami also spent a year in business development with UK Trade and Investment, where she was responsible for assisting US-based biotechnology and medical device companies understand the business opportunities that exist in the United Kingdom.
Ami holds a master’s in public health in epidemiology from The George Washington
University and a bachelor’s in biology from Duquesne University.